Thursday, October 19, 2017

WORLD CONFERENCE ON LUNG CANCER WEDNESDAY PRESS CONFERENCE: PD-1/PD-L1 ADVANCEMENTS AND INTERVENTIONS TO PREVENT AND TREAT LUNG CANCER

YOKOHAMA, Japan, Oct 19 (Bernama-GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung cancer and improve quality of life for lung cancer patients.

Innovations in lung cancer treatment linked to the discovery of PD-1
Prof. Tasuku Honjo of Japan, who was the first to identify PD-1 in 1992, shared an update on how PD-1 blockers have been widely used to treat many types of cancers. After decades of study, research into PD-1 has led to breakthrough immunotherapy treatments that are being hailed as a “penicillin moment” in cancer treatment.

http://mrem.bernama.com/viewsm.php?idm=30329

No comments:

Post a Comment